Correction

Prescribing hormone replacement therapy: key considerations for primary care physicians. Rima Chakrabarti, Rina Chakrabarti. Br J Gen Pract 2023; DOI: https://doi.org/10.3399/bjgp23x733473. The article has been revised for a number of corrections, including: Table 1 dosage for ‘Medroxyprogesterone’ under ‘Continuous combined regimen’ has been corrected to: ‘Minimum of 2.5 mg daily up to 5 mg daily’. Key consideration 4, under ‘Testosterone’ corrected text now reads ‘… transdermal preparations available in the UK can either be administered daily or on alternate days’. Address for correspondence corrected for Rima Chakrabarti.